FINWIRES · TerminalLIVE
FINWIRES

最新消息:受美国通胀持续高企的报告提振,美元走软,收益率下跌,金价上涨。

By

-- (更新价格。) 周四午后,美元走软,黄金价格走高。此前公布的数据显示,美国一项关键通胀指标上月上涨,而第一季度国内生产总值(GDP)增幅低于预期。 6月交割的黄金期货价格上涨71.30美元,至每盎司4,632.80美元,仍维持在过去一个月200美元的区间内。 美国经济分析局(BEA)公布的数据显示,美联储首选的通胀指标——3月份个人消费支出(PCE)指数环比增长0.7%,高于2月份的0.4%,但符合Marketwatch的预期。剔除波动较大的食品和能源价格后的核心PCE指数年化增长3.2%,高于2月份的3.0%,同样符合预期。 统计局还发布了美国第一季度GDP增速的初步估值,报告显示该指标增速为2.0%,高于上一季度的0.5%,低于市场预期的2.2%。 尽管市场预期随着伊朗战争推高通胀,利率即将上调,但黄金价格依然上涨。美联储政策委员会周三结束了为期两天的会议,维持利率不变,但暗示随着通胀攀升,加息可能在即。 盛宝银行写道:“尽管周三的联邦公开市场委员会(FOMC)会议维持利率不变,但债券收益率上升,美元走强,黄金仍吸引了新的需求。不过,由于伊朗战争持续影响经济前景,几位委员表示希望消除宽松倾向。” 尽管如此,受经济数据的影响,美元早盘大幅走低,ICE美元指数最新下跌0.81点至98.15。美国国债收益率也出现下跌,两年期美国国债收益率最新下跌 7.1 个基点至 3.894%,十年期国债收益率下跌 3.7 个基点至 4.397%。

Related Articles

Sectors

Sector Update: Financial

Financial stocks were higher late Thursday afternoon, with the NYSE Financial Index rising 1.3% and the State Street Financial Select Sector SPDR ETF (XLF) up 0.5%.The Philadelphia Housing Index climbed 1.6%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) added 1.5%.Bitcoin (BTC-USD) rose 0.9% to $76,409, and the yield for 10-year US Treasuries decreased 2.8 basis points to 4.39%.In corporate news, AvalonBay Communities (AVB) and Equity Residential (EQR) have held discussions over a potential merger, which would be one of the biggest real estate deals ever, Bloomberg reported. AvalonBay shares were down 1.1%, and Equity Residential was fractionally lower.

$AVB$EQR
Australia

Market Chatter: Zuckerberg, Cook Not Exploring Seattle Seahawks Bid

Meta Platforms (META) CEO Mark Zuckerberg and Apple (AAPL) CEO Tim Cook are not pursuing a bid for the National Football League's Seattle Seahawks, Bloomberg reported on Thursday, citing company and industry sources.A Meta spokesperson said Zuckerberg is not making any investment or bid for the team, while a person familiar with Cook's plans denied his involvement, the report said.Meta and Apple did not immediately respond to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $616.43, Change: $-52.69, Percent Change: -7.87%

$AAPL$META
Australia

Axsome Therapeutics Says FDA Approves Auvelity for Alzheimer's Disease Agitation

Axsome Therapeutics (AXSM) said Thursday the US Food and Drug Administration approved Auvelity for the treatment of agitation associated with Alzheimer's disease dementia.The approval was supported by two phase 3 clinical trials that showed the drug significantly improved agitation symptoms and resulted in a longer time to relapse compared with placebo.The medication acts on N-methyl-D-aspartate and sigma-1 receptors in the brain and is also approved for adults with major depressive disorder, the company added.Shares of Axsome were up more than 12% in Thursday trading.Price: $206.45, Change: $+22.50, Percent Change: +12.23%

$AXSM